Detalhe da pesquisa
1.
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers.
bioRxiv
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38617260
2.
KDM5A Inhibits Antitumor Immune Responses Through Downregulation of the Antigen-Presentation Pathway in Ovarian Cancer.
Cancer Immunol Res
; 10(8): 1028-1038, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726891